Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants (Q40418399)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants (English)

1 reference

Europe PubMed Central

20 September 2017

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

author name string

C Olivier

1

1 reference

Europe PubMed Central

20 September 2017

B H Belohradsky

2

1 reference

Europe PubMed Central

20 September 2017

S Stojanov

3

1 reference

Europe PubMed Central

20 September 2017

E Bonnet

4

1 reference

Europe PubMed Central

20 September 2017

G Petersen

5

1 reference

Europe PubMed Central

20 September 2017

J G Liese

6

1 reference

Europe PubMed Central

20 September 2017

language of work or name

0 references

publication date

6 May 2008

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

26

1 reference

Europe PubMed Central

20 September 2017

25

1 reference

Europe PubMed Central

20 September 2017

3142-3152

1 reference

Europe PubMed Central

20 September 2017

The epidemiology of pneumococcal disease in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

[Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in England and Wales: vaccination implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Paediatric, invasive pneumococcal disease in Switzerland, 1985-1994. Swiss Pneumococcal Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Outcomes of bacterial meningitis in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

[The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, thre

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of pneumococcal infections in Swedish children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.096

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40418399&oldid=1897301228"